Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a study published in Neuron, ...

Researchers have developed a laboratory model that mimics the pathological aggregation of TDP-43, a key protein in ALS and ...

Most of us rely heavily on shipping services like FedEx or UPS to ensure we receive the correct packages. If that system was ...

A court in Trieste has rejected a request filed by Martina Oppelli, who has had the fatal nerve-wasting disease Amyotrophic ...

Damaged muscles in ALS patients release proteins previously linked only to brain disease In a nutshell Researchers discovered that phosphorylated tau proteins, long thought to be exclusive Alzheimer’s ...

This article introduces the role of kinases in neurodegenerative diseases, the development of kinase inhibitors for the ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of new preclinical research in Free Radical Biology and Medicine, highlighting the role of edaravone in mitigating TDP-43 ...

The ALS research landscape is evolving rapidly, with groundbreaking advancements shaping the future of therapeutic ...

For years, the Alzheimer’s disease field has been on a quest for the perfect blood marker. Such a test could spare patients from invasive lumbar punctures, broaden care access, and allow AD cases to ...

With the initial phase of Empire AI up and running, select UB researchers are employing the center’s powerful computers to ...

Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology. However, biomarker detection, which is now part of the diagnostic ...